Trade

with

BioProspect Ltd
(ASX: BPO)
AdChoices
=
0.0030
0.0000
0.00%
After Hours :
-
-
-

Open

0.0030

Previous Close

0.0030

Volume (Avg)

7.99M (8.04M)

Day's Range

0.0030-0.0030

52Wk Range

0.0010-0.0050

Market Cap.

10.52M

Dividend Rate ( Yield )

-

Beta

2.07

Shares Outstanding

-

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 0

    • Net Income

    • -428.33k

    • Market Cap.

    • 10.52M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.07

    • Forward P/E

    • -

    • Price/Sales

    • -

    • Price/Book Value

    • 3.88

    • Price/Cash flow

    • -13.74

      • EBITDA

      • -320.32k

      • Return on Capital %

      • -8.19

      • Return on Equity %

      • -16.32

      • Return on Assets %

      • -8.19

      • Book Value/Share

      • 0.00

      • Shares Outstanding

      • -

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

          • Sales (Revenue)

            Q/Q (last year)

          • -

          • Net Income

            YTD/YTD (last year)

          • -

          • Net Income

            Q/Q (last year)

          • -

          • Sales (Revenue)

            5-Year Annual Average

          • 0.00

          • Net Income

            5-Year Annual Average

          • -

          • Dividends

            5-Year Annual Average

          • -

          • Profit Margins (%)

          • Company

            • Gross Margin

            • -

            • Pre-Tax Margin

            • -

            • Net Profit Margin

            • -

            • Average Gross Margin

              5-Year Annual Average

            • -

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • Financial Ratios

            • Company

              • Debt/Equity Ratio

              • 0.15

              • Current Ratio

              • 0.12

              • Quick Ratio

              • 0.12

              • Interest Coverage

              • -2.97

              • Leverage Ratio

              • 1.86

              • Book Value/Share

              • 0.00

              • Price Ratios

              • Company

                • Current P/E Ratio

                • -14.99

                • P/E Ratio 5-Year High

                • -250.00

                • P/E Ratio 5-Year Low

                • -4.17

                • Price/Sales Ratio

                • -

                • Price/Book Value

                • 3.88

                • Price/Cash Flow Ratio

                • -13.74

                • Key Metrics

                • Company

                  • Return on Equity %

                    (5-Year Average)

                  • -16.32

                    (-142.50)

                  • Return on Assets %

                    (5-Year Average)

                  • -8.19

                    (-80.30)

                  • Return on Capital %

                    (5-Year Average)

                  • -6.71

                    (-114.00)

                  • Income/Employee

                  • -

                  • Inventory Turnover

                  • -

                  • Asset Turnover

                  • -

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -790.49k
                  Operating Margin
                  -
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -13.74
                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Hard Assets

                  Style

                  Small Growth

                  BioProspect Ltd is engaged in developing and commercializing natural products and technology in the human health and personal care, animal health and nutrition and agricultural sectors. It also invests in oil & gas exploration.

                  Key People

                  Vincent John Paul Fayad

                  Non-Executive Chairman

                  Peter Donald May

                  Chief Operating Officer

                  Claude Solitario

                  Executive Director

                  Peter May

                  Non-Executive Director

                  Silvi Elkhouri

                  Non-Executive Director

                  • BioProspect Ltd

                  • Suite 25, 145 Stirling Highway

                  • Nedlands, WA 6009

                  • AUS.Map

                  • Phone: +61 893893170

                  • Fax: +61 893893199

                  • bioprospect.com

                  Incorporated

                  1998

                  Employees

                  4